» Articles » PMID: 33520840

Intervention of Ayurvedic Drug Attenuates the Metabolic Alterations in Hypertriglyceridemia: a Pilot Clinical Trial

Overview
Specialty Endocrinology
Date 2021 Feb 1
PMID 33520840
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hypertriglyceridemia (HG) is an independent risk factor with more prevalence than hypercholesterolemia and its attributes to cardiovascular disease (CVD) and pancreatitis. Hence, it becomes imperative to search for new triglyceride (TG) lowering agents. (TC) is a well-known Ayurvedic drug and a rich source of protoberberine alkaloids hence can contribute to TG lowering without side effects. Hence, to explore the therapeutic efficacy of T. cordifolia and its effects on biochemistry and metabolome in the patients of hyper-triglyceridemia, clinical trials were conducted.

Methods: Patients (n = 24) with hypertriglyceridemia were randomized into two groups to receive T. cordifolia (TCE) (3.0 g/per day) and metformin (850 mg/day) for 14 days having >300 mg/dl triglyceride level and cholesterol in the range of 130-230 mg/dl. Lipid profiles of blood samples were analyzed. Urine samples were subjected to HPLC-QTOF-MS to quantify oxidative damage and abnormal metabolic regulation.

Results: Intervention with TCE reduced the triglyceride, LDL, and VLDL levels to 380.45 ± 17.44, 133.25 ± 3.18, and 31.85 ± 5.88 mg/dL and increased the HDL to 47.50 ± 9.05 mg/dL significantly (p < 0.05) in the HG patients after 14 days treatment. TCE dosage potently suppressed the inflammatory and oxidative stress marker's i.e. levels of isoprostanes significantly (p < 0.01). Qualitative metabolomics approach i.e. PCA and PLS-DA showed significant alterations (p < 0.05) in the levels of 40 metabolites in the urine samples from different groups.

Conclusion: TCE administration depleted the levels of markers of HG i.e. VLDL, TG, and LDL significantly. Metabolomics studies established that the anti-HG activity of TCE was due to its antioxidative potential and modulation of the biopterin, butanoate, amino acid, and vitamin metabolism.

Clinical Trials Registry: India (CTRI) registration no. CTRI- 2016-08-007187.

Citing Articles

Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review.

Mansouri M, Imenshahidi M, Rameshrad M, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39731594 DOI: 10.1007/s00210-024-03642-2.


Clinical Value of Hospital-Community-Family Integrated Nursing Model in the Treatment of Patients with Hyperlipidemia Pancreatitis.

Wu J, Liu J, Zhang L, Shu Y, Guo X, Gao A Int J Gen Med. 2023; 16:3219-3227.

PMID: 37546240 PMC: 10403048. DOI: 10.2147/IJGM.S421160.


Integrated omics analysis revealed the intervention modulated multiple signaling pathways in hypertriglyceridemia patients-a pilot clinical trial.

Shirolkar A, Yadav A, Nale A, Phogat J, Dabur R J Diabetes Metab Disord. 2022; 21(1):379-397.

PMID: 35673460 PMC: 9167413. DOI: 10.1007/s40200-022-00985-6.

References
1.
Singh R, Devi S, Gollen R . Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. Diabetes Metab Res Rev. 2014; 31(2):113-26. DOI: 10.1002/dmrr.2558. View

2.
Haque M, Jantan I, Bukhari S . Tinospora species: An overview of their modulating effects on the immune system. J Ethnopharmacol. 2017; 207:67-85. DOI: 10.1016/j.jep.2017.06.013. View

3.
Baskaran R, Bharathi Priya L, Sathish Kumar V, Vijaya Padma V . Tinospora cordifolia extract prevents cadmium-induced oxidative stress and hepatotoxicity in experimental rats. J Ayurveda Integr Med. 2018; 9(4):252-257. PMC: 6314239. DOI: 10.1016/j.jaim.2017.07.005. View

4.
Aoyagi K . Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation. Mol Cell Biochem. 2003; 244(1-2):11-5. View

5.
Neinast M, Jang C, Hui S, Murashige D, Chu Q, Morscher R . Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids. Cell Metab. 2018; 29(2):417-429.e4. PMC: 6365191. DOI: 10.1016/j.cmet.2018.10.013. View